• Clinical Endoscopy
• /
• 제56권2호
• /
• pp.203-213
• /
• 2023

Background/Aims: Intestinal metaplasia (IM) of the stomach is a precancerous condition that is often not visible during conventional endoscopy. Hence, we evaluated the utility of magnification endoscopy and methylene blue (MB) chromoendoscopy to detect IM. Methods: We estimated the percentage of gastric mucosa surface staining with MB, mucosal pit pattern, and vessel visibility and correlated it with the presence of IM and the percentage of metaplastic cells in histology, similar to the Operative Link on Gastric Intestinal Metaplasia (OLGIM) stage. Results: IM was found in 25 of 33 (75.8%) patients and in 61 of 135 biopsies (45.2%). IM correlated with positive MB staining (p<0.001) and other than dot pit patterns (p=0.015). MB staining indicated IM with better accuracy than the pit pattern or vessel evaluation (71.7% vs. 60.5% and 49.6%, respectively). At a cut-off point of 16.5% for the MB-stained gastric surface, the sensitivity, specificity, and accuracy of chromoendoscopy in the detection of advanced OLGIM stages were 88.9%, 91.7%, and 90.9%, respectively. The percentage of metaplastic cells detected on histology was the strongest predictor of positive MB staining. Conclusions: MB chromoendoscopy can serve as a screening method for detecting advanced OLGIM stages. MB mainly stains IM areas with a high concentration of metaplastic cells.

• Clinical Endoscopy
• /
• 제56권6호
• /
• pp.681-692
• /
• 2023

In general, gastroesophageal reflux disease (GERD) is diagnosed clinically based on typical symptoms and/or response to proton pump inhibitor treatment. Upper gastrointestinal endoscopy is reserved for patients presenting with alarm symptoms, such as dysphagia, odynophagia, significant weight loss, gastrointestinal bleeding, or anorexia; those who meet the criteria for Barrett's esophagus screening; those who report a lack or partial response to proton pump inhibitor treatment; and those with prior endoscopic or surgical anti-reflux interventions. Newer endoscopic techniques are primarily used to increase diagnostic yield and provide an alternative to medical or surgical treatment for GERD. The available endoscopic modalities for the diagnosis of GERD include conventional endoscopy with white-light imaging, high-resolution and high-magnification endoscopy, chromoendoscopy, image-enhanced endoscopy (narrow-band imaging, I- SCAN, flexible spectral imaging color enhancement, blue laser imaging, and linked color imaging), and confocal laser endomicroscopy. Endoscopic techniques for treating GERD include esophageal radiofrequency energy delivery/Stretta procedure, transoral incisionless fundoplication, and endoscopic full-thickness plication. Other novel techniques include anti-reflux mucosectomy, peroral endoscopic cardiac constriction, endoscopic submucosal dissection, and endoscopic band ligation. Currently, many of the new endoscopic techniques are not widely available, and their use is limited to centers of excellence.

• Clinical Endoscopy
• /
• 제56권4호
• /
• pp.479-489
• /
• 2023

Background/Aims: Accurate neoplastic prediction can significantly decrease costs associated with pathology and unnecessary colorectal polypectomies. Narrow-band imaging (NBI) and dual-focus (DF) mode are promising emerging optical technologies for recognizing neoplastic features of colorectal polyps digitally. This study aimed to clarify the clinical usefulness of NBI with and without DF assistance in the neoplastic prediction of small colorectal polyps (<10 mm). Methods: This cross-sectional study included 530 small colorectal polyps from 343 consecutive patients who underwent colonoscopy at the University Medical Center from September 2020 to May 2021. Each polyp was endoscopically diagnosed in three successive steps using white-light endoscopy (WLE), NBI, and NBI-DF and retrieved for histopathological assessment. The diagnostic accuracy of each modality was evaluated with reference to histopathology. Results: There were 295 neoplastic polyps and 235 non-neoplastic polyps. The overall accuracies of WLE, WLE+NBI, and WLE+NBI+NBI-DF in the neoplastic prediction of colorectal polyps were 70.8%, 87.4%, and 90.8%, respectively (p<0.001). The accuracy of WLE+NBI+NBI-DF was significantly higher than that of WLE+NBI in the polyp size ≤5 mm subgroup (87.3% vs. 90.1%, p<0.001). Conclusions: NBI improved the real-time neoplastic prediction of small colorectal polyps. The DF mode was especially useful in polyps ≤5 mm in size.

• 대한정형외과학회지
• /
• 제54권3호
• /
• pp.211-218
• /
• 2019

추간판 탈출증이란 추간판이 정상적으로 위치해야 할 자리에서부터 추간판 내부의 수핵이나 섬유륜이 탈출하는 질환을 지칭하며, 대부분 양호한 자연 경과를 거친다. 하지만 심각한 신경학적 증상이 있거나, 악화되는 신경 증상, 마미 증후군이 동반된 경우, 보존적 치료에 반응하지 않는 경우 등에 대해서는 수술적 치료가 권고된다. 수술 방법에는 고식적인 관혈적 방법, 현미경을 이용한 방법, 통형 견인기(tubular retractor)를 이용한 방법, 그리고 내시경을 이용한 방법에 이르기까지 다양한 방법들이 소개되었는데, 그 중 현미경적 추간판 제거술이 현재 표준 치료로 간주되고 있다. 내시경을 이용한 방법 중에서 두 개의 입구를 통한 내시경 척추 수술(biportal endoscopic spinal surgery, BESS)의 경우, 다른 방법에 비해 수술 기구들의 독자적인 움직임이 가능하여 자유로운 조작이 가능하며, 재발된 추간판 탈출증에 대해서도 추간판 제거가 비교적 수월하게 시행되고, 작은 피부 절개로 넓은 시야 확보가 가능하며, 지속적인 생리식염수의 세척으로써 습기나 안개를 지속적으로 제거해야 되는 번거로움을 덜 수 있고 술 후 감염률을 낮추는 효과도 있다. 기존의 관절경 및 척추 수술 기구들을 그대로 쓸 수 있다는 장점도 있으며, 약 2,700-6,700 lux의 밝은 조도 하에 최대 28-35배로 확대된 영상으로 수술하기 때문에 섬세한 조작이 가능하다. 따라서 이러한 장점을 지닌 두 개의 입구를 통한 BESS는 요추부 추간판 탈출증에 대한 이상적인 수술 방법으로 생각된다.